Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Fleshner

Showing results (171-180 of 266) with videos related to

Pageof 27
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2010
Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancerShabbir M H Alibhai, Henriette Breunis, Narhari Timilshina, et al.
Clinical Genitourinary Cancer|April 13, 2020
A Systematic Review and Network Meta-analysis of Novel Androgen Receptor Inhibitors in Non-metastatic Castration-resistant Prostate CancerAmanda E Hird, Diana E Magee, Bimal Bhindi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 19, 2010
Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary baseJoseph L Chin, John Srigley, Linda A Mayhew, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2008
A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studiesStephane Supiot, Shubber Shubbar, Neil Fleshner, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|September 14, 2013
CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 updateFred Saad, Sebastien Hotte, Charles Catton, et al.
World Journal of Urology|January 2, 2020
Gender-based psychological and physical distress differences in patients diagnosed with non-metastatic renal cell carcinomaRami Ajaj, Jaime Omar Herrera Cáceres, Alejandro Berlin, et al.
Nature Reviews. Urology|November 17, 2025
Author Correction: Atypical intraductal proliferation in prostate biopsy - a diagnostic grey zone with clinical implicationsRui M Bernardino, João Lobo, Jihad Kaouk, et al.
Urologic Oncology|September 28, 2019
An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patientsRenu Jeyapala, Shivani Kamdar, Ekaterina Olkhov-Mitsel, et al.
Nature Reviews. Urology|November 7, 2025
Atypical intraductal proliferation in prostate biopsy - a diagnostic grey zone with clinical implicationsRui M Bernardino, João Lobo, Jihad Kaouk, et al.
European Urology Oncology|June 16, 2019
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform ArchitectureRenu Jeyapala, Andrea J Savio, Ekaterina Olkhov-Mitsel, et al.
Pageof 27

Showing results (171-180 of 266) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2010
Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancerShabbir M H Alibhai, Henriette Breunis, Narhari Timilshina, et al.
Clinical Genitourinary Cancer|April 13, 2020
A Systematic Review and Network Meta-analysis of Novel Androgen Receptor Inhibitors in Non-metastatic Castration-resistant Prostate CancerAmanda E Hird, Diana E Magee, Bimal Bhindi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 19, 2010
Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary baseJoseph L Chin, John Srigley, Linda A Mayhew, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2008
A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studiesStephane Supiot, Shubber Shubbar, Neil Fleshner, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|September 14, 2013
CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 updateFred Saad, Sebastien Hotte, Charles Catton, et al.
World Journal of Urology|January 2, 2020
Gender-based psychological and physical distress differences in patients diagnosed with non-metastatic renal cell carcinomaRami Ajaj, Jaime Omar Herrera Cáceres, Alejandro Berlin, et al.
Nature Reviews. Urology|November 17, 2025
Author Correction: Atypical intraductal proliferation in prostate biopsy - a diagnostic grey zone with clinical implicationsRui M Bernardino, João Lobo, Jihad Kaouk, et al.
Urologic Oncology|September 28, 2019
An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patientsRenu Jeyapala, Shivani Kamdar, Ekaterina Olkhov-Mitsel, et al.
Nature Reviews. Urology|November 7, 2025
Atypical intraductal proliferation in prostate biopsy - a diagnostic grey zone with clinical implicationsRui M Bernardino, João Lobo, Jihad Kaouk, et al.
European Urology Oncology|June 16, 2019
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform ArchitectureRenu Jeyapala, Andrea J Savio, Ekaterina Olkhov-Mitsel, et al.
Pageof 27